Drug Interactions between Lonsurf and tamsulosin
This report displays the potential drug interactions for the following 2 drugs:
- Lonsurf (tipiracil/trifluridine)
- tamsulosin
Interactions between your drugs
No interactions were found between Lonsurf and tamsulosin. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Lonsurf
A total of 217 drugs are known to interact with Lonsurf.
- Lonsurf is in the drug class antineoplastic combinations.
- Lonsurf is used to treat the following conditions:
tamsulosin
A total of 311 drugs are known to interact with tamsulosin.
- Tamsulosin is in the drug class alpha blockers.
-
Tamsulosin is used to treat the following conditions:
- Benign Prostatic Hyperplasia
- Urinary Tract Stones (off-label)
Drug and food interactions
tamsulosin food
Applies to: tamsulosin
ADJUST DOSING INTERVAL: Food may delay the gastrointestinal absorption of tamsulosin. The time to maximum plasma concentration (Tmax) is reached by 4 to 5 hours under fasted conditions and by 6 to 7 hours when tamsulosin is administered with food. The delay in Tmax has the desirable effect of smoothing the tamsulosin plasma concentration profile, thereby reducing fluctuation of the plasma peak and trough concentrations with multiple dosing. Food may also affect the extent of absorption of tamsulosin. It has been reported that taking tamsulosin under fasted conditions results in a 30% increase in bioavailability (AUC) and 40% to 70% increase in peak plasma concentration (Cmax) compared to fed conditions. The effects of food on the pharmacokinetics of tamsulosin are consistent regardless of whether tamsulosin is taken with a light meal or a high-fat meal.
MANAGEMENT: To ensure uniformity of absorption, tamsulosin should be administered approximately one-half hour following the same meal each day.
References (1)
- (2001) "Product Information. Flomax (tamsulosin)." Boehringer-Ingelheim
trifluridine food
Applies to: Lonsurf (tipiracil / trifluridine)
ADJUST DOSING INTERVAL: Administration of trifluridine-tipiracil with a standardized high-fat, high-calorie meal has been shown to decrease trifluridine peak plasma concentration (Cmax) as well as tipiracil Cmax and systemic exposure (AUC) by approximately 40% compared to administration in a fasting state in patients with cancer given a single 35 mg/m2 dose. No change in trifluridine AUC was observed.
MANAGEMENT: Based on the observed correlation between increases in the Cmax of trifluridine and decreases in neutrophil counts, trifluridine-tipiracil should be taken within one hour after completion of the morning and evening meals.
References (1)
- (2015) "Product Information. Lonsurf (tipiracil-trifluridine)." Taiho Oncology, Inc.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.